Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accomplish, Ada, Aid, Alaska, aLupron, Aluvia, Amitiza, Anchorage, andApotex, andBanner, andBiaxin, andMylan, andSafeway, andTeva, andWockhardt, ARB, asSimcor, awaiting, back, bare, breakdown, Bronstein, byRite, chapter, commence, commodity, Companyo, conjunction, constipation, covenant, CR, Crohn, destruction, dose, eighteen, EleCare, Endeavor, excessive, extraction, face, Filero, Freedom, Genentech, Holger, idiopathic, incomplete, increasedHUMIRA, inequitable, insomnia, intense, interruption, invasion, Juven, Liepmann, Lite, lived, mail, marketsDepakote, member, Middleweight, Montana, Mountain, multiplied, niacin, Noncontrolling, NYU, observable, occurrence, ofBiaxin, ofNiaspan, ofXience, onset, Oswego, Oxepa, polymercoated, Promising, promptly, purification, recurring, rejected, releaseVicodin, RNA, Rozerem, RS, safer, schedule, scheduled, Schenectady, Sensitive, sizable, sleep, smaller, stemming, succeed, sue, theFreeStyle, theXience, theZoMaxx, unobservable, unsealed, View, wholly, willfully, Wockhardt, worldwideHUMIRA, Wyeth
Removed:
achievement, Aeroset, affirmed, Andrx, appeal, attributed, Binder, bovine, BSE, Calcijex, catastrophic, cattle, chewing, close, Colorado, compensatory, component, composite, confectionery, conspiring, constituted, content, core, Dempsey, detect, Elaine, encephalopathy, Enfer, EPS, estimable, Europe, fixation, Flash, Gary, Golden, Gonzalez, Goptin, gum, half, hyperparathyroidism, hypertension, implant, Improvement, incremental, indemnify, injectable, insulin, introducing, isolated, Isoptin, Jeffrey, Joseph, leader, Link, marketer, Mavik, McCullough, medication, MediSense, Minnesota, Modernization, nationally, offer, Optium, orthopedic, overpricing, oxycodone, OxyContin, Papillon, payor, PCx, personal, Pharma, Precision, prejudice, preliminary, Purdue, Quantum, reached, reintroducing, reorganization, residual, resolved, retired, separation, settle, shift, spinal, Spine, spongiform, stayed, submit, Survanta, Taisho, Tarka, Teva, TheraSense, Tokyo, Tracker, TrueMeasure, violated, viral, William, Wm, Wrigley, Xtra, Zemplar
Filing tables
Filing exhibits
Related press release
ABT similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Abbott Laboratories
Description of Base Salary of Named Executive Officers
Set forth below are the base salaries, effective December 31, 2007 and March 1, 2008, of the chief executive officer, chief financial officer, and Holger Liepmann, all of whom were named executive officers in 2007.
Miles D. White
Chairman of the Board and Chief Executive Officer
| Base Salary | ||
---|---|---|---|
December 31, 2007 | $ | 1,738,000 | |
March 1, 2008 | $ | 1,807,500 |
Thomas C. Freyman
Executive Vice President, Finance and
Chief Financial Officer
| Base Salary | ||
---|---|---|---|
December 31, 2007 | $ | 858,000 | |
March 1, 2008 | $ | 892,300 |
Holger Liepmann
Executive Vice President,
Global Nutrition
| Base Salary | ||
---|---|---|---|
December 31, 2007 | $ | 676,000 | |
March 1, 2008 | $ | 703,000 |
Abbott Laboratories Description of Base Salary of Named Executive Officers